0      0

AONN+ Annual 2020


THURS04 - General Session 3 | Beyond Efficacy, Toxicity, and Cost: Patients Define Cancer Care Value in the United States


Nov 5, 2020 11:30am ‐ Nov 5, 2020 12:45pm

Description

This session will address the heightened focus on the concept of cancer care “value” via patient perspectives and perceptions through existing assessments of patient preferences, values, and goals.

This qualitative study explores and examines real-life (patient) experiences as they have become actualized in peoples’ lives, and the study findings will be utilized to inform the future of value assessments and ultimately policies that impact the lives of patients and their families.

Learning Objectives:
  • Provide an overview of the concept of value assessment and the potential impact on cancer patients.
  • Explore factors cancer patients and survivors consider when defining value in cancer care.
  • Share the degree of alignment or conflict between the factors that patients and survivors deem critical to cancer care value and those factors of importance to value framework developers.
  • Discuss implications for practice, research, and policy.

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content